You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Yongliang Wang1, Dana N LeVine2, Margaret Gannon3
1Department of Physics and Astronomy, Iowa State University, Ames, IA 50011, USA.
This study introduces a new biosensor called the integrative tension sensor (ITS) that can map forces in single platelets with high resolution. Platelets transmit forces during adhesion and contraction, which are important for blood clotting. Current methods lack the precision needed for detailed force mapping in small cells like platelets. The ITS biosensor converts molecular tensions into fluorescent signals, allowing direct force measurement. The researchers found that platelets generate different force levels during adhesion and contraction. The biosensor also detected changes in force patterns when platelets were treated with an anti-platelet drug. These findings suggest the ITS could be used to study platelet function and assess drug effects. The study concludes that the ITS is a valuable tool for research and clinical applications in platelet biology.
Area of Science:
Background:
Understanding how platelets transmit forces is essential for studying hemostasis and thrombosis. Prior research has shown that integrins play a central role in platelet adhesion and contraction. However, existing methods for measuring cellular forces have limited resolution, making them unsuitable for small cells like platelets. This gap motivated the development of new tools capable of capturing submicron-scale forces. Current traction force microscopies lack the precision needed for detailed force mapping in single platelets. Researchers have explored various imaging techniques, but none have achieved the spatial resolution required for platelet-level analysis. Additionally, conventional methods rely on indirect measurements, which may not fully capture dynamic force changes. The need for a direct and high-resolution force measurement tool remains unmet in the field. This paper addresses that need by introducing a novel biosensor approach.
Purpose Of The Study:
The primary aim of this study was to develop a biosensor that could directly measure and map forces in single platelets with high spatial resolution. Platelet force dynamics are poorly understood due to limitations in current imaging techniques. The researchers sought to create a method that could capture submicron-scale forces in real time. This approach would allow for precise visualization of platelet adhesion and contraction forces. The motivation for this work stems from the clinical need to assess anti-platelet drug efficacy. Conventional methods lack the resolution to detect subtle force changes in individual platelets. By improving spatial resolution, the study aimed to provide new insights into platelet mechanobiology. The ultimate goal was to create a tool that could be used in both research and clinical settings to evaluate platelet function.
Main Methods:
The researchers developed a force-activatable biosensor called the integrative tension sensor (ITS). This biosensor converts molecular tensions into fluorescent signals, enabling direct force measurement. The ITS was designed to be activated by mechanical forces at the integrin level. Fluorescence imaging was used to capture force distribution in single platelets. The biosensor was tested in platelets under various conditions to assess its sensitivity. The study included experiments with and without the anti-platelet drug tirofiban. Platelet adhesion and contraction forces were analyzed using the ITS biosensor. The results were compared to conventional traction force microscopy to validate the new method's accuracy.
Main Results:
The ITS biosensor successfully mapped forces in single platelets at a resolution of 0.4 µm. The force distribution in platelets showed strong polarization, indicating directional force transmission. Treatment with tirofiban altered the force patterns, suggesting the ITS can detect drug effects. The biosensor revealed two distinct tension levels in platelets. During adhesion, tensions ranged from 12 to 54 piconewtons. During contraction, tensions exceeded 54 piconewtons. These findings indicate that platelets generate different force magnitudes depending on their state. The ITS provided higher resolution than conventional methods, making it more suitable for platelet studies. The results demonstrate the potential of the ITS for both research and clinical applications.
Conclusions:
The ITS biosensor offers a new way to study platelet forces with high spatial resolution. The authors suggest that this tool can improve understanding of platelet mechanobiology. The findings indicate that the ITS can detect drug effects on platelet forces. The biosensor's ability to capture submicron-scale forces is a significant advancement. The study proposes that the ITS could be used to assess anti-platelet drug efficacy. The two distinct tension levels observed suggest different force mechanisms during adhesion and contraction. The researchers propose that the ITS could be applied in drug development and clinical diagnostics. The study concludes that the ITS is a powerful biosensor for platelet research.
The study developed a biosensor called ITS that maps forces in single platelets at 0.4 µm resolution.
The ITS converts molecular tensions into fluorescent signals, enabling direct force measurement in platelets.
Platelets are small cells, so high-resolution force mapping is needed to capture detailed force dynamics.
Tirofiban altered platelet force patterns, suggesting the ITS can detect drug effects on platelet function.
The ITS detected two tension levels: 12–54 pN during adhesion and above 54 pN during contraction.
The authors propose the ITS could be used in antithrombotic drug development and platelet activity assessment.